1. Home
  2. BNTC vs ONDS Comparison

BNTC vs ONDS Comparison

Compare BNTC & ONDS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BNTC
  • ONDS
  • Stock Information
  • Founded
  • BNTC 1995
  • ONDS 2014
  • Country
  • BNTC United States
  • ONDS United States
  • Employees
  • BNTC N/A
  • ONDS N/A
  • Industry
  • BNTC Biotechnology: Pharmaceutical Preparations
  • ONDS Telecommunications Equipment
  • Sector
  • BNTC Health Care
  • ONDS Telecommunications
  • Exchange
  • BNTC Nasdaq
  • ONDS Nasdaq
  • Market Cap
  • BNTC 335.5M
  • ONDS 1.4B
  • IPO Year
  • BNTC N/A
  • ONDS N/A
  • Fundamental
  • Price
  • BNTC $13.24
  • ONDS $5.86
  • Analyst Decision
  • BNTC Strong Buy
  • ONDS Strong Buy
  • Analyst Count
  • BNTC 5
  • ONDS 3
  • Target Price
  • BNTC $26.00
  • ONDS $4.67
  • AVG Volume (30 Days)
  • BNTC 40.8K
  • ONDS 49.3M
  • Earning Date
  • BNTC 09-25-2025
  • ONDS 08-12-2025
  • Dividend Yield
  • BNTC N/A
  • ONDS N/A
  • EPS Growth
  • BNTC N/A
  • ONDS N/A
  • EPS
  • BNTC N/A
  • ONDS N/A
  • Revenue
  • BNTC N/A
  • ONDS $16,131,404.00
  • Revenue This Year
  • BNTC N/A
  • ONDS $246.94
  • Revenue Next Year
  • BNTC N/A
  • ONDS $161.09
  • P/E Ratio
  • BNTC N/A
  • ONDS N/A
  • Revenue Growth
  • BNTC N/A
  • ONDS 75.16
  • 52 Week Low
  • BNTC $8.06
  • ONDS $0.57
  • 52 Week High
  • BNTC $17.15
  • ONDS $6.19
  • Technical
  • Relative Strength Index (RSI)
  • BNTC 59.72
  • ONDS 79.19
  • Support Level
  • BNTC $12.57
  • ONDS $3.20
  • Resistance Level
  • BNTC $13.33
  • ONDS $4.33
  • Average True Range (ATR)
  • BNTC 0.60
  • ONDS 0.54
  • MACD
  • BNTC 0.10
  • ONDS 0.17
  • Stochastic Oscillator
  • BNTC 95.59
  • ONDS 89.02

About BNTC Benitec Biopharma Inc.

Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.

About ONDS Ondas Holdings Inc.

Ondas Holdings Inc designs, develops, manufactures, sells, and supports FullMAX Software Defined Radio (SDR) technology in the United States, Israel, and India. The company operates in two business segments namely Ondas Networks and Ondas Autonomous Systems. The company generates maximum revenue from Ondas Autonomous Systems through the sales of the Optimus system and separately priced support, maintenance, and ancillary services related to the sale of the Optimus system.

Share on Social Networks: